Skip to main content
Journal ArticleOPEN ACCESS

Dose finding study of sparfloxacin in single-dose therapy for female acute uncomplicated cystitis

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases (1992) 66(10) 1462-1472
DOI: 10.11150/kansenshogakuzasshi1970.66.1462
0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Sparfloxacin (SPFX) is a new quinolone compound with a long half-life of 16 hours and a potent antibacterial activity (MIC90:

Cite

CITATION STYLE

APA

Hirose, T., Yoshiaki, K., Yokoo, A., Umehara, T., Miyake, M., Takatsuka, K., … Miyao, N. (1992). Dose finding study of sparfloxacin in single-dose therapy for female acute uncomplicated cystitis. Kansenshogaku Zasshi. The Journal of the Japanese Association for Infectious Diseases, 66(10), 1462–1472. https://doi.org/10.11150/kansenshogakuzasshi1970.66.1462

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free